Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Updated Exercise Guidelines for Adults With Arthritis

Published: Thu, 19 Jul 2018 17:19:42 EDT
New recommendations from EULAR on physical activity for patients with inflammatory or osteoarthritis mirror those for the general population.
Medscape Medical News

Why Taking Care in Discharging a Patient Matters

Published: Thu, 19 Jul 2018 14:52:26 EDT
Patients and caregivers often feel abandoned and lose trust in health care professionals when they sense a lack of caring during transitions. With it, they feel better able to handle concerns and act on their doctors’ recommendations.
Kaiser Health News

Cured Meats Strongly, Independently Tied to Increased Mania Risk

Published: Thu, 19 Jul 2018 14:27:39 EDT
Eating nitrate-cured meats such as beef jerky and other processed meat snacks has been strongly linked to an increased risk for mania, new research shows.
Medscape Medical News

No Adverse Outcomes in Efforts to Reposition Breech Baby

Published: Thu, 19 Jul 2018 11:19:17 EDT
Attempts at external cephalic version are not linked with perinatal morbidity but are associated with greater likelihood of vaginal delivery, a new study shows.
Medscape Medical News
Displaying results 1-4 (of 20)
 1 - 2 - 3 - 4 - 5 


An eye drop for macular degeneration shows promise in animal studies

Published: Thu, 19 Jul 2018 15:13:26 +0000
A startup called Macregen has licensed an eye drop developed in the U.K. that can penetrate the cells of the retina and deliver a therapy to treat age-related macular degeneration. A trial in large animals with eyes similar to those of humans has produced promising results.

Hospital infection immunotherapy developer Aridis files for $34.5M IPO

Published: Thu, 19 Jul 2018 13:43:09 +0000
Immunotherapy developer Aridis Pharmaceuticals has filed for a $34.5 million IPO as it plans to move its fully human antibodies for hospital-related infections into late-phase clinical trials.

Stripped-down Vical ‘considering options’ after pipeline woes

Published: Thu, 19 Jul 2018 12:17:24 +0000
After a string of pipeline failures, Vical has called in advisers to help decide the future of the company. The move comes just over a month after Vical abandoned work on a genital herpes vaccine following a negative phase 2 trial.

Novartis pays €95M to bag dermatitis drug from Galapagos, MorphoSys

Published: Thu, 19 Jul 2018 11:09:34 +0000
Novartis is set to pay €95 million ($110 million) upfront for the global rights to Galapagos and MorphoSys’ anti-IL-17C antibody MOR106. The deal positions Novartis to take MOR106 forward in atopic dermatitis and other indications, handing over up to €850 million in milestones as it goes.
Displaying results 1-4 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy